Greenway Enters International Supply Deal with 4C LABS to Enhance Global Cannabis Reach
Greenway's Strategic Supply Agreement with 4C LABS
Greenway Greenhouse Cannabis Corporation, a premier Canadian cannabis cultivator, has recently announced a significant international supply agreement with 4C LABS, a leading UK-based medical cannabis company. This collaboration promises to enhance Greenway's footprint in the burgeoning global cannabis market and affirms the company's reputation for producing high-quality cannabis products.
The agreement establishes Greenway as a supplier of high-grade dried flower products for 4C LABS, known for its dedication to delivering superior medical cannabis solutions to patients throughout the UK. As Carl Mastronardi, the President of Greenway, stated, the company intends to leverage its established reputation in the Canadian market to meet the growing demand for medical cannabis internationally.
The Value of Canadian Cannabis
In recent years, Canadian cannabis has gained recognition as the benchmark for quality, safety, and overall value in the global market. Greenway's decision to partner with 4C LABS is a strategic move that not only allows them to reach a wider audience but also capitalizes on the robust distribution network that 4C LABS offers. As Mastronardi highlighted, Canadian cannabis is perceived as the